Tryp Therapeutics and Exopharm Limited Secure Pivotal 2 Cent Waiver From ASX
MELBOURNE, Australia, Jan. 31, 2022 /PRNewswire/ -- Exopharm Limited (ASX:EX1) has signed a Master Collaborative Services Agreement (MSA) with the Astellas Institute for Regenerative Medicine (AIRM).